AI, AMD and Absci

Advanced Micro Devices (AMD) Invests in Absci for AI-Driven Drug Discovery with High-Performance Computing Solutions
We recently published a list of 13 AI News and Ratings You Probably Missed. In this article, we are going to take a look at where Advanced Micro Devices, Inc. (NASDAQ:AMD) stands against other AI stocks.
AMD invests $20M in AI-powered drug discovery company Absci
Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop new hardware and software optimized for the healthcare sector. The effort will place particular emphasis on developing technologies that can advance drug discovery.
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery
Absci shares are rising after announcing a strategic collaboration with Advanced Micro Devices Inc. The partnership will enhance Absci's AI drug discovery capabilities using AMD Instinct accelerators and ROCm software.
AMD is going head-to-head with Nvidia in AI-backed drug discovery with new deal
Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
AMD partnering with drug-discovery company Absci
AMd (AMD) said via X that it is partnering with drug-discovery company Absci (ABSI). “AMD is proud to announce we are partnering with @abscibio
AMD Invests in Drug-Discovery Company Absci in Push to Sell AI Chips
The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other industries.
AMD invests $20 million in AI drug research at Vancouver-based Absci
Chip designer AMD said Wednesday that it will invest $20 million in Absci, the Vancouver company that aims to use artificial intelligence to develop new drug therapies. Absci hopes artificial intelligence will enable it to move faster to develop protein-based medicines called biologics,
Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery
Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, today announced a strategic collaboration with AMD to deploy AMD Instinct™ accelerators and ROCm™ software to power critical AI drug discovery workloads,
Why AMD (AMD) Shares Are Plunging Today
Shares of computer processor maker AMD (NASDAQ:AMD) fell 5.9% in the morning session after Goldman Sachs analyst Toshiya Hari ...
Nvidia vs. AMD: Putting the GPU giants side-by-side
On price alone, AMD has a leg up on Nvidia. AMD offers more affordable graphics card options, focusing on the budget and ...
AMD: Expect Bears To Feast On Overhyped Data Center Opportunity
AMD’s AI advancements are overshadowed by Nvidia’s CUDA. Find out why AMD stock is overvalued, while NVDA continues to lead ...
TweakTown4d
AMD's Adrenalin software for Radeon GPUs is getting AI features for RDNA 4
AMD's new Adrenalin AI for RDNA 4 graphics cards brings several local generative AI tools to next-gen Radeon GPUs, for ...
Hosted on MSN1d
Could AMD Join the League of the Magnificent 7?
The Magnificent Seven group is a tough league to break into. Just when you think the group is about to slow down and give up ...
AMD: A Strong Buy As AI Datacenter Ramps Up In 2025
Advanced Micro Devices' diversified revenue streams provide a cushion against potential slowdowns in AI hardware CapEx. See ...
I tried FSR 4 on a new AMD Radeon RX 9070 XT graphics card, and it looks great
We tested AMD's latest AI resolution upscaling tech on its new gaming GPU with Ratchet & Clank, and it looks massively better ...
Why AMD (AMD) Shares Are Falling Today
Shares of computer processor maker AMD (NASDAQ:AMD) fell 5.2% in the morning session after the company received a double ...
AMD announces new driver-based AI for 'AMD-related questions', local file summaries, and image generation for its new line of graphics cards
We also don't yet know how this AI is being done and through which AI model. It could be in-house, which would explain part ...